<DOC>
	<DOCNO>NCT00270439</DOCNO>
	<brief_summary>The purpose study determine whether laparoscopic removal omentum ( thin layer fat inside abdomen ) significantly improve insulin resistance patient non-insulin dependent type 2 diabetes mellitus .</brief_summary>
	<brief_title>Omentectomy Treatment Diabetes Mellitus Type 2</brief_title>
	<detailed_description>Clinical study show central obesity one strong association Type II diabetes . Measurement waist circumference Vanderbilt one effective clinical measure presence type II diabetes response gastric bypass recent study . This central obesity point omentum one major culprit development perpetuation type II diabetes human . [ 1 ] Animal study Vanderbilt show normal size dog surgical removal visceral fat ( Omentectomy ) : - Decreases basal hepatic glucose production nearly 40 % - Results decrease FFA delivery liver - Increases glucose utilization peripheral insulin dependent tissue , predominantly skeletal muscle . [ 2 ] The animal study start pursue positive result see Swedish investigator randomize 50 patient either gastric banding gastric band omentectomy . At 2 year group statistically similar weight loss patient omentectomy group 2 3 time improvements oral glucose tolerance , insulin sensitivity fast plasma glucose compare control subject . [ 3 ] They conclude omentectomy , combine gastric band morbidly obese patient significant positive effect glucose insulin metabolism . Why removal visceral fat ( small percentage animal 's weight ) cause 40 % increase peripheral glucose metabolism ? The omentum know repository macrophage increase macrophage number proportional increase adiposity human . Both macrophage adipocytes produce adipokines cytokine know influence glucose insulin metabolism . The omentum also know major contributor Free Fatty Acids portal circulation adversely affect hepatic insulin resistance . Resection visceral fat hold number macrophage turn release cytokine preferentially disturb glucose metabolism theory result mark improvement glucose fat metabolism . Hypothesis Removal visceral fat ( omentectomy ) significantly improve type II Diabetes dyslipidemia . Specific Aim 1 : Determine improvement glucose metabolism patient type II diabetes use Minimal model study baseline 3 month post surgery Specific Aim 2 : Determine improvement control type II diabetes measure HgbA1c level amount oral medication take control diabetes 3 , 6 12 month post surgery . Specific aim 3 : Determine improvement lipid measure fast serum total cholesterol , HDL , LDL Triglycerides 0 , 3 , 6 , 12 month post surgery . Specific Aim 4 : Determine effect omentectomy marker inflammation ( C- reactive protein , interleukin 6 ) 3 , 6 , 12 month post op . These labs drawn assay see effect insulin resistance .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>age 1855 BMI 3050 Dyslipidemia Noninsulin dependent Type 2 diabetes Mellitus oral hypoglycemics Medicare patient significant hepatic enzyme elevation ( 50 % upper limit normal ) serum creatinine &gt; 1.5 mg/dl history ketoacidosis current metabolic acidosis current use oral anticoagulant positive pregnancy test ( βhuman chorionic gonadotrophin ) females intercurrent infection take drug know affect carbohydrate lipid metabolism ( e.g . steroid , high dose Niacin , βadrenergic receptor agonist , include antidiabetic drug )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Omentectomy</keyword>
	<keyword>Diabetes Mellitus Type 2</keyword>
	<keyword>Laparoscopic</keyword>
	<keyword>Dyslipidemia</keyword>
</DOC>